Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

11
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
11
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

14
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
14
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

14
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
14
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

12
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
12
Goiter01:27

Goiter

22
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
22
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

392
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does preoperative administration of Lugol's solution in patients undergoing thyroidectomy for Graves' disease really improve surgical outcomes? A propensity score matching analysis from six high-volume centers (StELLinA study).

Updates in surgery·2026
Same author

De-Escalating Thyroid Cancer Surgery: Insights and Unresolved Questions From the 2025 ATA Guidelines.

Annali italiani di chirurgia·2026
Same author

Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis.

JCI insight·2026
Same author

Risk of Complications in Patients Undergoing Thyroidectomy for Graves' Disease (LUNA Study).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms.

European journal of endocrinology·2026
Same author

Correction: Aligning perspectives: towards a standardized concept of "complexity" in thyroid surgery-an international web-based survey.

Updates in surgery·2026

Related Experiment Video

Updated: Apr 24, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.2K

Differentiated thyroid cancer in the elderly: our experience.

Pietro Giorgio Calò1, Fabio Medas1, Giulia Loi1

  • 1Department of Surgical Sciences, University of Cagliari, Cagliari, Italy.

International Journal of Surgery (London, England)
|September 4, 2014
PubMed
Summary

Differentiated thyroid cancer in elderly patients shows more aggressive characteristics. However, total thyroidectomy is a safe and effective surgical option when performed by experienced surgeons.

Keywords:
ElderlyThyroid cancerThyroidectomy

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 24, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.2K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Area of Science:

  • Endocrinology
  • Oncology
  • Geriatric Medicine

Background:

  • Differentiated thyroid cancer (DTC) presents unique challenges in elderly populations.
  • Understanding the clinical and pathological differences in older patients is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical and pathologic characteristics of DTC in elderly patients (≥65 years).
  • To evaluate the outcomes of surgical treatment, specifically total thyroidectomy, in this demographic.

Main Methods:

  • Retrospective analysis of 455 patients diagnosed with DTC and treated with total thyroidectomy.
  • Patients were stratified into two groups: elderly (Group A, n=101) and younger (Group B, n=354).
  • Comparison of surgical outcomes, histopathological findings, and complication rates between the two groups.

Main Results:

  • Elderly patients (Group A) had a significantly longer postoperative hospital stay (2.8 vs. 2.4 days).
  • Histopathological differences included a higher frequency of follicular variant papillary carcinoma and tall cell carcinoma in Group A.
  • While complication rates were generally low in both groups, transient hypoparathyroidism was more common in Group A (24.8% vs. 13.6%).

Conclusions:

  • Differentiated thyroid carcinoma appears more aggressive in elderly patients due to biological factors and potential diagnostic delays.
  • Total thyroidectomy is a safe and recommended surgical procedure for elderly patients with DTC.
  • Experienced surgical teams are essential for optimal outcomes in this patient population.